The Food and Drug Administration[1] is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other "high-risk" individuals, while increasing the standard of evidence to approve COVID vaccines for low-risk
...
Read more https://www.foxnews.com/politics/trump-fda-overhauls-covid-19-vaccine-approval-focus-older-populations-high-risk-individuals